RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xenon Pharmaceuticals Stock

Xenon Pharmaceuticals ROE 2024

Xenon Pharmaceuticals ROE

-0.2

Ticker

XENE

ISIN

CA98420N1050

WKN

A12ETN

In 2024, Xenon Pharmaceuticals's return on equity (ROE) was -0.2, a 13.51% increase from the -0.17 ROE in the previous year.

Xenon Pharmaceuticals Aktienanalyse

What does Xenon Pharmaceuticals do?

Xenon Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of innovative therapies for rare diseases. It was founded in 1996 and is headquartered in Burnaby, British Columbia, Canada, with additional offices in the United States and Europe. The company has become a leading biotech company in the industry and focuses on identifying and developing treatments for rare diseases through its proprietary platform called Extreme Genetics. Xenon Pharmaceuticals has a wide pipeline of clinical candidates targeting diseases such as ichthyosis, X-linked adrenoleukodystrophy, pain disorders, and epilepsy. It collaborates with pharmaceutical companies to utilize its platform technology and expertise in the research of rare diseases. Its key drug candidate is XEN496 for the treatment of epilepsy. Overall, Xenon Pharmaceuticals plays a significant role in the biotech industry and continues to make progress in developing innovative therapies for rare diseases. Xenon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Xenon Pharmaceuticals's Return on Equity (ROE)

Xenon Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Xenon Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Xenon Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Xenon Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Xenon Pharmaceuticals stock

What is the ROE (Return on Equity) of Xenon Pharmaceuticals this year?

The ROE of Xenon Pharmaceuticals this year is -0.2 undefined.

How has the Return on Equity (ROE) of Xenon Pharmaceuticals developed compared to the previous year?

The ROE of Xenon Pharmaceuticals has increased by 13.51% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Xenon Pharmaceuticals?

A high ROE indicates that Xenon Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Xenon Pharmaceuticals?

A low ROE can indicate that Xenon Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Xenon Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of Xenon Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Xenon Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Xenon Pharmaceuticals?

Some factors that can influence Xenon Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Xenon Pharmaceuticals pay?

Over the past 12 months, Xenon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xenon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Xenon Pharmaceuticals?

The current dividend yield of Xenon Pharmaceuticals is .

When does Xenon Pharmaceuticals pay dividends?

Xenon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xenon Pharmaceuticals?

Xenon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Xenon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xenon Pharmaceuticals located?

Xenon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xenon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xenon Pharmaceuticals from 11/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Xenon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Xenon Pharmaceuticals in the year 2023?

In the year 2023, Xenon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Xenon Pharmaceuticals pay out the dividend?

The dividends of Xenon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Xenon Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Xenon Pharmaceuticals

Our stock analysis for Xenon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xenon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.